Get the Stockscreener App
1.19
5.56%
-0.07
After Hours:
1.22
0.03
+2.52%
Pyxis Oncology Inc Stock (PYXS) Forecast
The Pyxis Oncology Inc (PYXS) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $3.917, representing a +229.16% increase from the current price of $1.19. The highest analyst price target is $3.9246, and the lowest is $3.9095.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month PYXS Price Target
Average 2.8385
(+138.53% Upside)
Is Pyxis Oncology Inc (PYXS) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 59.07 | Neutral |
| STOCH(9,6) | 66.99 | Neutral |
| STOCHRSI(14) | 73.17 | Neutral |
| MACD(12,26) | 0.0272 | Buy |
| ADX(14) | 27.34 | Buy |
| William %R | -30.63 | Neutral |
| CCI(14) | 132.11 | Buy |
Buy: 3
Sell: 0
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.098
Buy
|
1.1079
Buy
|
| MA20 |
1.0226
Buy
|
1.07
Buy
|
| MA50 |
1.0683
Buy
|
1.1421
Buy
|
| MA100 |
1.3016
Sell
|
1.4757
Sell
|
| MA200 |
2.3805
Sell
|
2.1339
Sell
|
Buy: 6
Sell: 4
Neutral: 0
Summary: Buy
According to our latest analysis, PYXS could be considered a Strong Buy, with 17 technical analysis indicators signaling 9 Buy signals, 4 signaling Sell signals and 4 Neutral signals. This might be a good time to open fresh positions on PYXS, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 59.07 indicates that PYXS is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 66.99 indicates that PYXS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 73.17 indicates that PYXS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 27.34 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 132.11 indicates that PYXS is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term PYXS price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Pyxis Oncology Inc financial reports and earnings history, Pyxis Oncology Inc (PYXS) stock could reach $1.0949 by 2030, $31.71 by 2040 and $21.92 by 2050. See the projected annual prices until 2050 of the Pyxis Oncology Inc stock below:
- Pyxis Oncology Inc (PYXS) is expected to reach an average price of $14.27 in 2035, with a high prediction of $14.38 and a low estimate of $14.29. This indicates an $1,099% rise from the last recorded price of $1.19.
- Pyxis Oncology Inc (PYXS) stock is projected to chart a bullish course in 2040, with an average price target of $30.96, representing an $2,502% surge from its current level. The forecast ranges from a conservative $31.07 to a sky-high $31.71.
- Our analysts predict Pyxis Oncology Inc (PYXS) to jump 4,215% by 2045, soaring from $51.37 to an average price of $51.35, potentially reaching $50.95. While $51.37 is the low estimate, the potential upside is significant.
- Pyxis Oncology Inc (PYXS) stock is expected to climb by 2050, reaching an average of $23.53, a $1,877% jump from its current level. However, a wide range of estimates exists, with high and low targets of $21.92 and $22.12, respectively, highlighting the market's uncertainty.
Pyxis Oncology Inc Stock (PYXS) Year by Year Forecast
Pyxis Oncology Inc Stock (PYXS) Price Forecast for 2025
Pyxis Oncology Inc Stock (PYXS) is expected to reach an average price of $2.9162 in 2025, with a high prediction of $4.2192 and a low estimate of $1.6132. This indicates an +145.06% rise from the last recorded price of $1.19.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2025 | $3.8895 | $3.9095 | $3.9246 | +226.85% |
| July, 2025 | $4.1467 | $4.2267 | $4.0618 | +248.47% |
| August, 2025 | $4.1865 | $4.2042 | $4.2192 | +251.81% |
| September, 2025 | $3.7463 | $3.9163 | $4.064 | +214.82% |
| October, 2025 | $3.4836 | $3.6687 | $3.6543 | +192.74% |
| November, 2025 | $3.2734 | $2.8959 | $2.7484 | +175.07% |
| December, 2025 | $1.4106 | $1.6132 | $2.2508 | +18.54% |
Pyxis Oncology Inc Stock (PYXS) Price Forecast for 2026
The predicted value for Pyxis Oncology Inc (PYXS) in 2026 is set at an average of $1.8632. Estimates vary from a peak of $3.662 to a trough of $0.0644, indicating an +56.57% surge from the present price of $1.19.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $1.4704 | $1.9481 | $1.713 | +23.56% |
| February, 2026 | $1.2902 | $1.4579 | $1.3528 | +8.42% |
| March, 2026 | $1.93 | $1.6451 | $1.805 | +62.19% |
| April, 2026 | $1.7472 | $1.8423 | $1.7975 | +46.83% |
| May, 2026 | $2.037 | $1.8647 | $1.757 | +71.18% |
| June, 2026 | $1.9568 | $1.9419 | $1.8845 | +64.44% |
| July, 2026 | $2.2641 | $2.0266 | $1.9241 | +90.26% |
| August, 2026 | $2.2439 | $2.1864 | $2.1715 | +88.56% |
| September, 2026 | $1.7611 | $2.0211 | $2.1488 | +47.99% |
| October, 2026 | $1.3709 | $1.6909 | $1.716 | +15.20% |
| November, 2026 | $0.4593 | $0.2493 | $1.0358 | -61.40% |
| December, 2026 | $3.172 | $0.0644 | $3.662 | +166.56% |
Pyxis Oncology Inc Stock (PYXS) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Pyxis Oncology Inc (PYXS) is $5.7983, with a high forecast of $11.02 and a low forecast of $0.5748. This indicates an +387.25% increase from the last price of $1.19.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.9322 | $0.9322 | $3.6671 | -21.66% |
| February, 2027 | $1.2324 | $0.5748 | $3.1873 | +3.57% |
| March, 2027 | $3.4749 | $1.265 | $2.7949 | +192.01% |
| April, 2027 | $2.8445 | $2.9596 | $2.0945 | +139.03% |
| May, 2027 | $3.8041 | $5.6641 | $5.6643 | +219.67% |
| June, 2027 | $4.9086 | $5.289 | $4.8886 | +312.49% |
| July, 2027 | $7.9382 | $6.3085 | $6.3582 | +567.07% |
| August, 2027 | $8.4778 | $8.0831 | $8.7829 | +612.42% |
| September, 2027 | $9.9522 | $9.3027 | $9.6773 | +736.32% |
| October, 2027 | $11.32 | $10.97 | $10.80 | +851.41% |
| November, 2027 | $10.61 | $10.72 | $11.02 | +791.72% |
| December, 2027 | $10.32 | $10.33 | $10.50 | +766.88% |
Pyxis Oncology Inc Stock (PYXS) Price Forecast for 2028
In 2028, Pyxis Oncology Inc (PYXS) is projected to reach an average price of $8.0139, with a high projection of $9.8521 and a low estimate of $6.1757. This indicates an +573.44% rise from the last price of $1.19.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $9.8455 | $9.8406 | $9.8521 | +727.35% |
| February, 2028 | $9.4651 | $9.5653 | $9.5804 | +695.39% |
| March, 2028 | $9.9796 | $9.3998 | $9.7296 | +738.62% |
| April, 2028 | $9.9692 | $10.03 | $9.7492 | +737.75% |
| May, 2028 | $9.9237 | $9.669 | $9.7237 | +733.92% |
| June, 2028 | $9.8233 | $9.7684 | $9.6435 | +725.48% |
| July, 2028 | $9.3529 | $9.4629 | $9.7183 | +685.95% |
| August, 2028 | $8.8674 | $8.9074 | $9.1478 | +645.16% |
| September, 2028 | $7.9469 | $8.0969 | $8.7323 | +567.81% |
| October, 2028 | $7.7465 | $7.9718 | $7.7667 | +550.97% |
| November, 2028 | $6.681 | $6.5263 | $6.2511 | +461.43% |
| December, 2028 | $6.2406 | $6.1757 | $6.4959 | +424.42% |
Pyxis Oncology Inc Stock (PYXS) Price Forecast for 2029
The 2029 price forecast for Pyxis Oncology Inc Stock (PYXS) is $3.1654 on average, with a high prediction of $6.295 and a low estimate of $0.0358. This represents an +166.00% increase from the previous price of $1.19.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $6.3851 | $6.0884 | $6.0901 | +436.56% |
| February, 2029 | $6.2147 | $6.2347 | $6.295 | +422.24% |
| March, 2029 | $5.9443 | $6.1594 | $6.1197 | +399.52% |
| April, 2029 | $5.9439 | $6.0739 | $6.049 | +399.49% |
| May, 2029 | $5.8484 | $6.0636 | $5.9515 | +391.46% |
| June, 2029 | $6.008 | $5.9633 | $6.0431 | +404.87% |
| July, 2029 | $5.8676 | $5.9929 | $5.8627 | +393.07% |
| August, 2029 | $5.407 | $5.452 | $5.6725 | +354.37% |
| September, 2029 | $4.5016 | $4.7066 | $5.127 | +278.29% |
| October, 2029 | $1.0561 | $2.0061 | $2.6665 | -11.25% |
| November, 2029 | $0.6157 | $0.0358 | $0.551 | -48.26% |
| December, 2029 | $0.5253 | $1.7253 | $1.5704 | -55.86% |
Pyxis Oncology Inc Stock (PYXS) Price Forecast for 2030
Pyxis Oncology Inc Stock (PYXS) is expected to reach an average price of $9.3502 in 2030, with a high forecast of $17.66 and a low forecast of $1.0402. This signifies an +685.73% surge from the last price of $1.19.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.0676 | $1.0402 | $1.0949 | -10.29% |
| February, 2030 | $9.907 | $11.16 | $10.44 | +732.52% |
| March, 2030 | $13.86 | $10.51 | $13.12 | +1,064% |
| April, 2030 | $11.67 | $12.64 | $12.39 | +880.32% |
| May, 2030 | $13.94 | $12.69 | $12.11 | +1,071% |
| June, 2030 | $16.68 | $14.49 | $14.61 | +1,301% |
| July, 2030 | $17.03 | $16.23 | $16.39 | +1,331% |
| August, 2030 | $17.76 | $16.84 | $17.21 | +1,392% |
| September, 2030 | $17.33 | $17.70 | $17.66 | +1,356% |
| October, 2030 | $16.99 | $17.08 | $17.18 | +1,328% |
| November, 2030 | $15.99 | $16.21 | $16.81 | +1,244% |
| December, 2030 | $15.63 | $15.75 | $15.80 | +1,213% |
0.39%
3.66%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):